Provided by Tiger Trade Technology Pte. Ltd.

Cohen & Steers

73.79
+0.97001.33%
Post-market: 73.790.00000.00%19:30 EDT
Volume:408.49K
Turnover:30.05M
Market Cap:3.79B
PE:22.70
High:74.04
Open:72.67
Low:71.97
Close:72.82
52wk High:86.56
52wk Low:58.39
Shares:51.39M
Float Shares:27.75M
Volume Ratio:1.26
T/O Rate:1.47%
Dividend:2.58
Dividend Rate:3.50%
EPS(TTM):3.25
EPS(LYR):2.97
ROE:27.33%
ROA:14.54%
PB:6.43
PE(LYR):24.85

Loading ...

Silo Pharma Receives U.S. Patent Allowance for SPC-15 PTSD Treatment, Expanding Intellectual Property Portfolio

GlobeNewswire
·
Yesterday

Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Yesterday

Press Release: Cabot Corporation to Expand North American Battery Materials Platform Through Modified $50 Million DOE Grant

Dow Jones
·
Sep 17

NeOnc Technologies Redeems All Outstanding Series A Convertible Preferred Stock and Eliminates Related Potential Dilution

GlobeNewswire
·
Sep 17

Axsome Therapeutics Presents Ten Posters Exemplifying its Innovative Psychiatry and Neurology Portfolio at Psych Congress 2026

GlobeNewswire
·
Sep 17

Press Release: NeOnc Executives Invest Approximately $629,000 in Open-Market Stock Purchases Following Positive Neo100 Phase 2a Results

Dow Jones
·
Sep 16

Canaccord Genuity Keeps Their Buy Rating on Corero Network Security (CNS)

TIPRANKS
·
Sep 10

Cohen & Steers Fund Manager Discloses 2.92% Stake in Prologis

Reuters
·
Sep 10

Cohen & Steers' August Assets Under Management Decline

MT Newswires Live
·
Sep 10

Cohen & Steers AUM Slips to $101 Billion at Aug. 31, 2026

Reuters
·
Sep 10

Cohen & Steers Announces Preliminary Assets Under Management and Net Flows for August 2026

THOMSON REUTERS
·
Sep 10

Cohen & Steers - Reports Preliminary Aum of $101 Bln as of August 31, 2026

THOMSON REUTERS
·
Sep 10

Cohen & Steers is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Sep 10

Silo Pharma to Highlight Patented Nose-to-Brain Drug Delivery Technology for PTSD at 2026 Nasal Innovation Forum

GlobeNewswire
·
Sep 09

Press Release: NeOnc Technologies Holdings, Inc. Announces Pricing of $15 Million Registered Direct Offering Priced At-the-Market Under NASDAQ Rules with New and Existing Institutional Investors

Dow Jones
·
Sep 09

Bright Minds Biosciences to Present at Upcoming Conferences

GlobeNewswire
·
Sep 05

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 04

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 04

Cohen & Steers Fund Manager Buys 632 Prologis Shares at up to USD 137.51

Reuters
·
Sep 03

Supernus Pharmaceuticals to Participate in September Investor Conferences

GlobeNewswire
·
Sep 03